Which company does Axitinib come from?

Axitinib is produced by Pfizer Pharmaceuticals of the United States. Axitinib is used in combination with avelumab for the initial treatment of advanced renal cell carcinoma. In combination with pembrolizumab for the initial treatment of advanced renal cell carcinoma. Axitinib is also used as monotherapy for advanced renal cell carcinoma(RCC) after failure of one systemic therapy.

Monitor ALT, AST and bilirubin concentrations regularly during treatment. Consider more frequent monitoring when axitinib is used concomitantly with avelumab or pembrolizumab, consider regular monitoring of LVEF, and monitor for signs and symptoms of heart failure periodically during treatment. , Monitor for signs of gastrointestinal perforation or fistula, Monitor blood pressure regularly. Monitor thyroid function regularly during treatment, Treat hypothyroidism and hyperthyroidism according to standard medical practice to maintain euthyroidism, Monitor proteinuria regularly during treatment.

Combined therapy with avelumab as first-line treatment for advanced renal cell carcinoma(≥20%) Side effects include diarrhoea, fatigue, hypertension, musculoskeletal pain, nausea, mucositis, Palmar-Paresthesia of the soles of the feet(Hand-foot syndrome), dysphonia, decreased appetite, hypothyroidism, rash, liver toxicity, cough, dyspnea, abdominal pain, headache. Combined use of pembrolizumab in the first-line treatment of advanced renal cell carcinoma(≥20%) Side effects include diarrhea, fatigue, asthenia, hypertension, hypothyroidism, decreased appetite, hepatotoxicity, hand and foot Paresthesia(Hand-foot syndrome), nausea, stomatitis/Mucosal inflammation, dysphonia, rash, cough, constipation. Advanced renal cell carcinoma(Incidence rate≥20%)Monotherapy for second-line treatmentSide effects include diarrhea, hyperemia Pressure, fatigue, loss of appetite, nausea, dysphonia, palmar-plantar red blood cell paresthesias(Hand-foot syndrome), weight loss, vomiting, fatigue, constipation. There are generic drugs in Bangladesh. The retail price of Bangladesh Beacon Pharmaceutical is about 1,800 yuan for 5 mg and 60 tablets. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.